Senior industry leader brings substantial strategy, business development, and operations experience SOUTH SAN FRANCISCO, Calif., Aug. 22, 2023 /PRNewswire/ — Neuron23™ Inc., a clinical-stage biotechnology company focused on developing precision medicines for genetically defined…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.